References
Keith, B., Johnson, R.S. & Simon, M.C. Nat. Rev. Cancer 12, 9–22 (2012).
Semenza, G.L. Cell 148, 399–408 (2012).
Shen, C. et al. Cancer Discov. 1, 222–235 (2011).
Koivunen, P. et al. Nature 483, 484–488 (2012).
Purdue, M.P. et al. Nat. Genet. 43, 60–65 (2011).
Dang, L. et al. Nature 462, 739–744 (2009).
DeBerardinis, R.J. & Thompson, C.B. Cell 148, 1132–1144 (2012).
Lu, C. et al. Nature 483, 474–478 (2012).
Turcan, S. et al. Nature 483, 479–483 (2012).
Li, Z. et al. Cancer Cell 15, 501–513 (2009).
Mazumdar, J. et al. Proc. Natl. Acad. Sci. USA 107, 14182–14187 (2010).
Choi, C. et al. Nat. Med. 18, 624–629 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Young, R., Simon, M. Untuning the tumor metabolic machine: HIF-α: pro- and antitumorigenic?. Nat Med 18, 1024–1025 (2012). https://doi.org/10.1038/nm.2865
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2865
- Springer Nature America, Inc.
This article is cited by
-
Hyperbaric oxygen promotes not only glioblastoma proliferation but also chemosensitization by inhibiting HIF1α/HIF2α-Sox2
Cell Death Discovery (2021)
-
Soft tissue sarcomas: IVIM and DKI correlate with the expression of HIF-1α on direct comparison of MRI and pathological slices
European Radiology (2021)
-
MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition
Scientific Reports (2016)
-
Rare insights into cancer biology
Oncogene (2014)